Jaguar動物健康 JAGX 深 滬
等待開盤 09-26 09:30:00 美东时间
7.78
+0.720
+10.20%
華盛通- 最 高12.10
- 今 開9.09
- 成交量 2835.86万股
- 最 低 6.80
- 昨 收 7.06
- 總市值 404.67万
- 52周最高 1267.875
- 市盈率 靜 --
- 換手率 5.45%
- 52周最低 2.48
- 委 比 -67.09%
- 總股本 52.01万
- 歷史最高 1313490937500.00
- 量 比 4.56
- 振 幅 75.07%
- 歷史最低 2.9985
- 每 手 1
- 風險率 369.85%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多Jaguar Health Stock Plunges Wednesday: What's Happening?
Jaguar Health Inc. (NASDAQ:JAGX) shares are plunging Wednesday morning as profit-taking reverses an explosive Tuesday rally sparked by regulatory fee waivers. Jaguar Health stock is taking a hit today. What’s behind JAGX decline? Low-Float Volatility and Profit-Taking The sharp downward correction f...
09-23 22:31
FDA Grants Jaguar Health Family Company Napo Pharma's Request For Waiver Of Fee Associated With PDUFA For Mytesi For 2027 Fiscal Year
Company remains sharply focused on its ongoing rare disease intestinal failure global development program for microvillus inclusion disease (MVID) and SBS for crofelemer powder for oral solution, targeting an NDA filing for MVID mid-2027 SAN FRANCISCO, CA / ACCESS Newswire / September 22, 2026 / Jag...
09-22 21:07
Jaguar Animal Health Announces Major Equity Recapitalization
An announcement from Jaguar Animal Health ( ($JAGX) ) is now available. On Sept...
09-22 05:18
Jaguar Animal Health expands ownership and restructures equity
Jaguar Animal Health ( ($JAGX) ) has shared an announcement. On September 11, 2...
09-16 02:17
Jaguar Health sets 1-for-15 reverse stock split; shares crash
Jaguar Health (JAGX) announced on Tuesday that it will execute a 1-for-15 reverse stock split on September 17, 2026, to support compliance with Nasdaq listing requirements. The stock will begin tradin...
09-15 21:09
Jaguar Health To Effect 1-For-15 Reverse Stock Split Of Common Stock On September 17
Reverse split approved at April 2026 Special Meeting of Stockholders Shares of Jaguar Health common stock to begin trading on split-adjusted basis on September 17, 2026 Reverse split approved at April 2026 Special Meeting of Stockholders Shares of Jaguar Health common stock to begin trading on split...
09-15 21:03
Jaguar Health shares are trading lower. The company announced its Napo unit provided crofelemer for treatment of congenital sodium diarrhea in an infant and said it plans to file for FDA approval for MVID in 2027.
Jaguar Health shares are trading lower. The company announced its Napo unit provided crofelemer for treatment of congenital sodium diarrhea in an infant and said it plans to file for FDA approval for MVID in 2027.
09-04 22:36
Jaguar Health Initiates Commercial Roll Out Of Neonorm Dog
Jaguar Health, Inc. (NASDAQ:JAGX) ("Jaguar") today announced the initiation of the commercial launch of Neonorm Dog, a new extension of Jaguar's Neonorm franchise for companion and production animals. Neonorm Dog is designed to provide dog owners with access to a plant-based, non-prescription produc...
08-26 21:10
Jaguar Health Reports Q2 2026 Results: Full Earnings Call Transcript
Jaguar Health (NASDAQ:JAGX) released second-quarter financial results and hosted an earnings call on Wednesday. Read the complete transcript below. Benzinga APIs provide real-time access to earnings call transcripts and financial data. Visit https://www.benzinga.com/apis/ to learn more. The full ear...
08-20 05:18
Jaguar Health Q2 EPS $(15.70) Up From $(358.94) YoY, Sales $1.225M Down From $2.979M YoY
Jaguar Health (NASDAQ:JAGX) reported quarterly losses of $(15.70) per share. This is a 95.63 percent increase over losses of $(358.94) per share from the same period last year. The company reported $1.225 million in sales this quarter. This is a 58.88 percent decrease over sales of $2.979 million th...
08-20 03:49
